Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lymphoma, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/21/2019 |
| Start Date: | August 2008 |
| End Date: | December 2019 |
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma After Radiation Therapy/Anthracycline Chemotherapy
This study is to inquire by mailed survey regarding the cardiac and general health of
patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation
therapy/anthracycline chemotherapy.
patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation
therapy/anthracycline chemotherapy.
Inclusion Criteria:
- All patients with Hodgkin's Lymphoma and Non Hodgkin's lymphoma who underwent
Radiation Therapy (RT) to either a mantle or modified mantle field with or without
adriamycin at the Wilmot Cancer Center at the University of Rochester are eligible for
the study.
Exclusion Criteria:
- Any severe preexisting cardiac disease (e.g., arrhythmia, angina, coronary disease,
myocardial infarction, or congestive heart failure) prior to diagnosis
We found this trial at
1
site
Univ of Rochester Medical Center One of the nation's top academic medical centers, the University...
Click here to add this to my saved trials
